Rosacea Review

Fall 2007

• FEATURE: NRS-Funded Studies Shine Light on Potential New Treatment Advances
• BRIEF: Breakthrough Study Wins Wide Coverage
• FEATURE: Cosmetics Help Appearance in Some But Aggravate Rosacea in Others
• Q & A: Answers to Readers' Questions
• TIPS: Tips for Coping with the Holidays
• READER SURVEY ON ROSACEA
• FEATURE: Special Care, New Technology Aid Ocular Rosacea
• SUCCESS STORY: She Finds the Finishing Touch for Her Rosacea

Breakthrough Study Wins Wide Coverage

The National Rosacea Society (NRS) funded research study on the role of cathelicidins in rosacea (see associated article) was recently published by Yamasaki et al. in Nature Medicine, one of the most prestigious medical scientific journals.¹ It not only alerted the medical community to these new findings, but raised public awareness of rosacea through media coverage nationwide.

The paper was covered by newspapers across the country as a result of reports by Associated Press, United Press International, the Los Angeles Times syndicate and many others. The discovery was also featured on network and local television and in national magazines.

"This breakthrough research was made possible by the membership donations of individuals who join the NRS and contributed to medical research," said Dr. Jonathan Wilkin, chairman of the NRS Medical Advisory Board. "With continued support, our research grants program should continue to make major discoveries toward improving the treatment, prevention and potential cure of this often life-disruptive disorder."

Associated Reference

1. Yamasaki K, DiNardo A, Bardan A, et al. Increased serine protease activity and cathelicidins promotes skin inflammation in rosacea. Nature Medicine. 2007;13:975-980.